S-carvedilol

S-卡维地洛

Report date: 2022/03/15 14:00:36

Base Information

Drug NameS-carvedilol
Drug Alias NameSCT101AGSCT-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonistsVoltage-gated calcium channel blockersAdrenergic receptor alpha-1 antagonists
TargetsBeta adrenergic receptorsVoltage-gated calcium channelAdrenergic receptors alpha-1
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/01/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAhn-Gook
China Registration ClassN/A

Develop Information

Active CompaniesAhn-Gook
Inactive CompaniesAhn-Gook Pharmaceutical Co Ltd
Active IndicationsHypertension
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeC02
Related LinksN/A